A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
Clinical trial NCT05644392 · UNKNOWN
Trial details
- NCT number
- NCT05644392
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-25
- Primary completion
- 2025-11-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.